These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 23773640)

  • 21. Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.
    Liu X; Wang L; Zhou K; Shao S; Hua Y; Wu M; Liu L; Wang C
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):24. PubMed ID: 33712036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset.
    Fukunishi M; Kikkawa M; Hamana K; Onodera T; Matsuzaki K; Matsumoto Y; Hara J
    J Pediatr; 2000 Aug; 137(2):172-6. PubMed ID: 10931407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K
    J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease.
    Kobayashi T; Kobayashi T; Morikawa A; Ikeda K; Seki M; Shimoyama S; Ishii Y; Suzuki T; Nakajima K; Sakamoto N; Arakawa H
    J Pediatr; 2013 Aug; 163(2):521-6. PubMed ID: 23485027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent endothelial damage after intravenous immunoglobulin therapy in Kawasaki disease.
    Sakurai Y; Takatsuka H; Onaka M; Takada M; Nishino M
    Int Arch Allergy Immunol; 2014; 165(2):111-8. PubMed ID: 25401215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC; Yang KD; Liang CD; Bong CN; Yu HR; Wang L; Wang CL
    Pediatr Allergy Immunol; 2007 Jun; 18(4):354-9. PubMed ID: 17584314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease.
    Hamada H; Suzuki H; Abe J; Suzuki Y; Suenaga T; Takeuchi T; Yoshikawa N; Shibuta S; Miyawaki M; Oishi K; Yamaga H; Aoyagi N; Iwahashi S; Miyashita R; Honda T; Onouchi Y; Terai M; Hata A
    Cytokine; 2012 Dec; 60(3):681-5. PubMed ID: 22944461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population.
    Tang Y; Yan W; Sun L; Huang J; Qian W; Ding Y; Lv H
    Clin Rheumatol; 2016 Nov; 35(11):2771-2776. PubMed ID: 27491972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
    Liu F; Ding Y; Yin W
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1109-12. PubMed ID: 24342209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease.
    Ha KS; Lee J; Jang GY; Lee J; Lee KC; Son CS; Lee JW
    Am J Cardiol; 2015 Jul; 116(2):301-6. PubMed ID: 25975725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verification of Current Risk Scores for Kawasaki Disease in Korean Children.
    Shin J; Lee H; Eun L
    J Korean Med Sci; 2017 Dec; 32(12):1991-1996. PubMed ID: 29115081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting IVIG resistance in UK Kawasaki disease.
    Davies S; Sutton N; Blackstock S; Gormley S; Hoggart CJ; Levin M; Herberg JA
    Arch Dis Child; 2015 Apr; 100(4):366-8. PubMed ID: 25670405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin failure and retreatment in Kawasaki disease.
    Durongpisitkul K; Soongswang J; Laohaprasitiporn D; Nana A; Prachuabmoh C; Kangkagate C
    Pediatr Cardiol; 2003; 24(2):145-8. PubMed ID: 12457253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study.
    Kanai T; Takeshita S; Kawamura Y; Kinoshita K; Nakatani K; Iwashima S; Takizawa Y; Hirono K; Mori K; Yoshida Y; Nonoyama S
    Heart Vessels; 2020 Oct; 35(10):1463-1472. PubMed ID: 32449049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease.
    Kawamura Y; Takeshita S; Kanai T; Yoshida Y; Nonoyama S
    J Pediatr; 2016 Nov; 178():281-284.e1. PubMed ID: 27526622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness.
    Wang Y; Li Z; Hu G; Hao S; Deng X; Huang M; Ren M; Jiang X; Kanegaye JT; Ha KS; Lee J; Li X; Jiang X; Yu Y; Tremoulet AH; Burns JC; Whitin JC; Shin AY; Sylvester KG; McElhinney DB; Cohen HJ; Ling XB;
    PLoS One; 2016; 11(12):e0167434. PubMed ID: 28002448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.
    Lin MT; Chang CH; Sun LC; Liu HM; Chang HW; Chen CA; Chiu SN; Lu CW; Chang LY; Wang JK; Wu MH
    J Formos Med Assoc; 2016 May; 115(5):350-5. PubMed ID: 25910931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do cytokines correlate with refractory Kawasaki disease in children?
    Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
    Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
    Li W; Zhang L; Wang Z; He X; Lin H; Wang Y; Yuan J; Xie X; Zhang X; Qin Y; Huang P
    Int J Clin Pract; 2022; 2022():2726686. PubMed ID: 35989868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.